投資有価証券売却益、Impairment LossEL - Chemistry Reportable Segments Member、Minority Interests他2件
- 【期間】
| 年度 | 投資有価証券売却益 | Impairment LossEL - Chemistry Reportable Segments Member | Minority Interests | Retirement Benefit LiabilityNCLIFRS | 四半期包括利益合計 |
|---|
| 2010/09 | - | | - | | - | | - | | - | |
| 2011/09 | - | | - | | - | | - | | - | |
| 2012/09 | - | | - | | - | | - | | - | |
| 2013/09 | 311億 | | - | | - | | - | | - | |
| 2014/09 | 52.7億 | -83.1% | - | | - | | - | | - | |
| 2015/09 | - | | - | | - | | - | | - | |
| 2016/09 | - | | - | | - | | - | | - | |
| 2017/09 | - | | - | | - | | - | | - | |
| 2018/09 | 287億 | +445.2% | - | | - | | - | | 845億 | |
| 2019/09 | - | | - | | - | | - | | 122億 | -85.5% |
| 2020/09 | - | | - | | - | | - | | -2071億 | 赤転 |
| 2021/09 | - | | - | | - | | - | | 4041億 | 黒転 |
| 2022/09 | - | | - | | - | | - | | 6001億 | +48.5% |
| 2023/09 | - | | - | | - | | - | | 5574億 | -7.1% |
